Guidance

Hepatitis B: antenatal screening and selective neonatal immunisation pathway

Guidance on the delivery of antenatal screening and selective neonatal immunisation services for pregnant women living with hepatitis B and their babies.

• From: UK Health Security Agency
• Published: 8 January 2021
• Last updated: 11 August 2023 — See all updates

Documents

Guidance on the hepatitis B antenatal screening and selective neonatal immunisation pathway

Ref: PHE publications gateway number: GW-1799

HTML

Guidance on the hepatitis B antenatal screening and selective neonatal immunisation pathway (print version)

Ref: PHE publications gateway number: GW-1799

PDF, 1.37 MB, 72 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance was originally published by Public Health England. It is currently being reviewed and due to be republished by UK Health Security Agency (UKHSA).

This document provides a chronological description of the hepatitis B antenatal screening and selective neonatal and infant immunisation pathways with required actions and signposting to patient information and resources to support safe and effective delivery of the services.

Published 8 January 2021
Last updated 11 August 2023 + show all updates

1. 11 August 2023

   Corrected Payment for administration section regarding ages for vaccine administration.

2. 8 January 2021

   First published.